Perry B. Molinoff

15.6k citations

170 papers · 12.6k indexed · 5 hit papers · h-index 58

Impact in

Cellular and Molecular Neuroscience top 0.1%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Neuropeptides and Animal Physiology
Behavioral Neuroscience top 1%

Papers in

Cellular and Molecular Neuroscience 82
- Neuroscience and Neuropharmacology Research 39
- Neurotransmitter Receptor Influence on Behavior 28
- Neuropeptides and Animal Physiology 25
Animal Science and Zoology 35
- Pharmacological Effects and Assays 35

Co-authors: Kenneth P. Minneman Gregory A. Weiland Keith Williams Julius Axelrod Barry B. Wolfe Linda R. Hegstrand B B Wolfe Richard M. Weinshilboum
Journals: Journal of Pharmacology and Experimental Therapeutics (35 papers)Molecular Pharmacology (22 papers)Journal of Neurochemistry (14 papers)Brain Research (10 papers)Biochemical Pharmacology (7 papers)
Partner nations: United States United Kingdom Czechia

In The Last Decade

Perry B. Molinoff

170 papers receiving 11.8k citations

Hit Papers

5 papers align trajectories log scale

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors 2002 · 736 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Journal of Pharmacology and Experimental Therapeutics
1994 Pharmacological Reviews
1981 Life Sciences
1979 Molecular Pharmacology
1971 PubMed

Peers

Countries citing papers authored by Perry B. Molinoff

Since Specialization

Citations

This map shows the geographic impact of Perry B. Molinoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry B. Molinoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry B. Molinoff more than expected).

Fields of papers citing papers by Perry B. Molinoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perry B. Molinoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry B. Molinoff. The network helps show where Perry B. Molinoff may publish in the future.

Co-authors

The 25 scholars most cited alongside Perry B. Molinoff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Perry B. Molinoff Line = papers co-authored together Perry B. Molinoff links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra® International Journal of Impotence Research ·R. Rosen, L E Diamond, Dennis Earle, A. M. Shadiack, Perry B. Molinoff	2004	67
2	PT‐141: A Melanocortin Agonist for the Treatment of Sexual Dysfunction Annals of the New York Academy of Sciences ·Perry B. Molinoff, A. M. Shadiack, Dennis Earle, L E Diamond, Check Y. Quon	2003	72
3	Use of subunit-specific antisense oligodeoxynucleotides to define developmental changes in the properties of N-methyl-D-aspartate receptors. Molecular Pharmacology ·Jie Zhong, Valentin K. Gribkoff, Perry B. Molinoff	1996	14
4	Lack of Discrimination by Agonists for D2 and D3 Dopamine Receptors Neuropsychopharmacology ·Kevin D. Burris, Mary A. Pacheco, Theresa M. Filtz, Mei‐Ping Kung, Hank F. Kung, Perry B. Molinoff	1995	27
5	Expression of the Human 5-Hydroxytryptamine1A Receptor in Sf9 Cells Journal of Biological Chemistry ·Paul Butkerait, Sören Soennecken, Hazem Hallak, Timothy E. Graham, Heather A. Miller, Kevin D. Burris, Perry B. Molinoff, David R. Manning	1995	143
6	Regulation of 5-HT2A receptor mRNA in P11 cells Behavioural Brain Research ·Edward Alejandro Romero Rodríguez, Perry B. Molinoff	1995	8
7	Agonists and antagonists differentially regulate the high affinity state of the D2L receptor in human embryonic kidney 293 cells. Molecular Pharmacology ·Virginia A. Boundy, Mary A. Pacheco, Wei Guan, Perry B. Molinoff	1995	34
8	Chapter 5 Molecular pharmacology of NMDA receptors: modulatory role of NR2 subunits Progress in brain research ·Perry B. Molinoff, Keith Williams, Dolan B. Pritchett, Jie Zhong	1994	23
9	SUBTYPES OF SEROTONIN RECEPTORS AND ANXIOLYTIC DRUGS: MODEL SYSTEMS FOR THE STUDY OF 5-HT RECEPTORS Clinical Neuropharmacology ·Perry B. Molinoff, C D Unsworth, Edward Alejandro Romero Rodríguez, Julie G. Hensler	1992	1
10	Modulation of the NMDA receptor by polyamines Life Sciences ·Keith Williams, Carmelo Romano, Marc A. Dichter, Perry B. Molinoff	1991	296
11	Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study Developmental Brain Research ·Peter A. Rao, Perry B. Molinoff, Jeffrey N. Joyce	1991	154
12	Polyamines Modulate the Binding of [³H]MK‐801 to the Solubilized N‐Methyl‐D‐Aspartate Receptor Journal of Neurochemistry ·Carmelo Romano, Keith Williams, Perry B. Molinoff	1991	25
13	Receptors for Monoamines on Cultured Cells American Journal of Hypertension ·Kathryn J. Ivins, Perry B. Molinoff	1990	1
14	Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors. Journal of Pharmacology and Experimental Therapeutics ·Margarita L. Contreras, B B Wolfe, Perry B. Molinoff	1986	50
15	Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells. Molecular Pharmacology ·R N Pittman, Perry B. Molinoff	1983	17
16	Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. Journal of Pharmacology and Experimental Therapeutics ·Raja R Palepu, Perry B. Molinoff	1982	134
17	The Pharmacological Specificity of Beta-1 and Beta-2 Adrenergic Receptors in Rat Heart and Lung in Vitro Molecular Pharmacology ·Kenneth P. Minneman, Linda R. Hegstrand, Perry B. Molinoff	1979	218
18	The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine. Journal of Pharmacology and Experimental Therapeutics ·Yuipco, Perry B. Molinoff, Charles O. Rutledge	1977	118
19	Binding of Iodinated Beta Adrenergic Antagonists to Proteins Derived from Rat Heart Molecular Pharmacology ·T. Kendall Harden, Barry B. Wolfe, Perry B. Molinoff	1976	73
20	AN ENZYMATIC ASSAY FOR OCTOPAMINE AND OTHER β-HYDROXYLATED PHENYLETHYLAMINES Journal of Pharmacology and Experimental Therapeutics ·Perry B. Molinoff, Lewis Landsberg, Julius Axelrod	1969	18

About Perry B. Molinoff

Perry B. Molinoff is a scholar working on Cellular and Molecular Neuroscience, Animal Science and Zoology, Biochemistry, Molecular Biology and Psychiatry and Mental health, having authored 170 papers that have together received 12.6k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (90 papers), Neuroscience and Neuropharmacology Research (39 papers), Pharmacological Effects and Assays (35 papers), Neurotransmitter Receptor Influence on Behavior (28 papers), Neuropeptides and Animal Physiology (25 papers), Ion channel regulation and function (17 papers), Adipose Tissue and Metabolism (14 papers) and Cancer, Stress, Anesthesia, and Immune Response (13 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (6.8k citations), Behavioral Neuroscience (520 citations), Animal Science and Zoology (1.1k citations), Molecular Biology (7.2k citations) and Endocrine and Autonomic Systems (668 citations). Perry B. Molinoff has collaborated with scholars based in United States, United Kingdom and Czechia. Frequent co-authors include Kenneth P. Minneman, Gregory A. Weiland, Keith Williams, Julius Axelrod, Barry B. Wolfe, Linda R. Hegstrand, B B Wolfe, Richard M. Weinshilboum, T K Harden and Anders Hedberg. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology, Journal of Neurochemistry, Brain Research and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact